<DOC>
	<DOC>NCT01240980</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety, tolerability and effect on blood glucose control of BMS-903452 compared to placebo in healthy subjects &amp; relative bioavailability of the crystalline and amorphous forms of BMS-903452 [Panels 4,6,11 &amp; 12(Part A)] ; and subjects with type 2 Diabetes Mellitus (Part B). The study will also determine the amount of BMS-903452 in the blood.</brief_summary>
	<brief_title>Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) &amp; Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 &amp; 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Clinically healthy or Clinical diagnosis of Type 2 diabetes on a stable dose of metformin monotherapy Type 1 Diabetes History of significant heart disease Prior bariatric surgery Women of childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>